ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

ClinicalTrials.gov ID: NCT03881059

Public ClinicalTrials.gov record NCT03881059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis (PsA)

Study identification

NCT ID
NCT03881059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
203 participants

Conditions and interventions

Interventions

  • BMS-986165 Dose A Drug
  • BMS-986165 Dose B Drug
  • BMS-986165 Placebo Other
  • Ustekinumab Drug
  • Ustekinumab Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2019
Primary completion
Apr 26, 2020
Completion
Jan 26, 2021
Last update posted
Feb 14, 2022

2019 – 2021

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Rheumatology Associates of North Alabama Huntsville Alabama 35801
Medvin Clinical Research - Covina Office Covina California 91722
University of California at San Diego Medical Center La Jolla California 92039
Arthritis & Rheumatic Disease Specialties Aventura Florida 33180
San Marcus Research Clinic Miami Lakes Florida 33014
Omega Research Consultants - Metrowest Orlando Florida 32835
Integral Rheumatology & Immunology Specialists Plantation Florida 33324
BayCare Medical Group St. Petersburg Florida 33705
University of South Florida - Morsani College of Medicine Tampa Florida 33612
Heartland Research Associates - East Wichita Wichita Kansas 67207
Arthritis Center of Lexington Lexington Kentucky 40504
Clinical Pharmacology Study Group Worcester Massachusetts 01605
Arthritis Associates Hattiesburg Mississippi 39402
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Atlantic Coast Rheumatology Toms River New Jersey 08755
Albuquerque Center for Rheumatology Albuquerque New Mexico 87102
The Center for Rheumatology-Albany Albany New York 12203
University of Rochester Medical Center Rochester New York 14642
Joint Muscle Medical Care and Research Institute - Lilington Office Charlotte North Carolina 28204
DJL Clinical Research Charlotte North Carolina 28210
PMG Research of Salisbury Salisbury North Carolina 28144
Paramount Medical Research and Consulting Middleburg Heights Ohio 44130
East Penn Rheumatology Associates Bethlehem Pennsylvania 18015
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Low Country Rheumatology Summerville South Carolina 29486
West Tennessee Research Institute Jackson Tennessee 38305
Office of Ramesh C. Gupta, MD Memphis Tennessee 38119
Pioneer Research Solutions Cypress Texas 77429-5890
Southwest Rheumatology Research Mesquite Texas 75150
Seattle Rheumatology Associates Seattle Washington 98122
Arthritis Northwest Rheumatology Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03881059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03881059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →